MODERN INTERPRETATION OF THE ETIOLOGY, PATHOGENESIS AND PREVENTION OF MYOCARDIAL DYSTROPHY
Том 1 № 4 (2024), Articles
Том 1 № 4 (2024)

MODERN INTERPRETATION OF THE ETIOLOGY, PATHOGENESIS AND PREVENTION OF MYOCARDIAL DYSTROPHY

Articles
Опубликован 2024-06-08
  • Shukurlayev Adhamjon
  • Yavgashev Asomiddin
  • Raxmonov Azamat
  • Baxrillayev Yusufxon
Shukurlayev Adhamjon
Yavgashev Asomiddin
Raxmonov Azamat
Baxrillayev Yusufxon
pdf

Ключевые слова

Myocardial dystrophy is often formed in a healthy heart. This means that the primary disease or condition is not caused by the heart, that is, it is related to the pathology of other organs and tissues, imbalance in the internal environment of the body, including intoxication and general fatigue.

Аннотация

This is a heart pathology that has not been identified as an independent diagnosis. Cardiologists use this term to refer to a group of diseases associated with improper nutrition of the heart muscle (myocardial dystrophy). As a result of metabolic disorders, dystrophic changes lead to dysfunction of myocardial muscle fibers. The energy balance in myocardial cells is disturbed. As a result, the heart's ability to contract decreases, the heart muscle cannot fully perform its function and cannot deliver oxygen and necessary nutrients to the organs and tissues.

pdf

Библиографические ссылки

Farrukh S. ORGANIZATION OF DIGITALIZED MEDICINE AND HEALTH ACADEMY AND ITS SIGNIFICANCE IN MEDICINE //Science and innovation. – 2023. – Т. 2. – №. Special Issue 8. – С. 493-499.

Sarkisova, V., Lapasova, Z., & Shernazarov, F. (2023). O. Rakhmanov INFLAMMATORY DISEASES OF THE PELVIC WOMEN ORGANS.

Shernazarov I., Shernazarov F. Problems of translation of features related to the way of life of peoples //Science and innovation. – 2023. – Т. 2. – №. B1. – С. 80-83.

Jalalova, D., Axmedov, A., Kuryazov, A., & Shernazarov, F. (2022). COMBINED DENTAL AND EYE PATHOLOGY. Science and innovation, 1(8), 91-100.

Shernazarov F., Zuhridinovna J. D. Microcirculation disorders in the vascular system of the bulbar conjunctiva in the initial manifestations of cerebral blood supply deficiency //Science and innovation. – 2022. – Т. 1. – №. Special Issue 2. – С. 515-522.

Solovyova, Y., Prostyakova, N., Sharapova, D., & Shernazarov, F. (2023). The relevance of psychotic disorders in the acute period of a stroke. Science and innovation, 2(D12), 212-217.

Rotanov, A., Karshiyev, Z., Sharapova, D., & Shernazarov, F. (2023). Diagnosis of depressive and suicidal spectrum disorders in students of a secondary special education institution. Science and innovation, 2(D11), 309-315.

Shernazarov F. COMBINED DENTAL AND EYE PATHOLOGY //Science and Innovation. – 2022. – Т. 1. – №. 8. – С. 91-100.

Madaminov M., Shernazarov F. Breast cancer detection methods, symptoms, causes, treatment //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 530-535.

Jalalova, D., Axmedov, A., Kuryazov, A., & Shernazarov, F. (2022). СОЧЕТАННАЯ СТОМАТОЛОГИЧЕСКАЯ И ГЛАЗНАЯ ПАТОЛОГИЯ. Science and innovation, 1(D8), 91-100.

Prostyakova, N., Solovyova, Y., Sharapova, D., & Shernazarov, F. (2023). Issues of professional ethics in the treatment and management of patients with late dementia. Science and innovation, 2(D12), 158-165.

Jalalova D., Raxmonov X., Shernazarov F. РОЛЬ С–РЕАКТИВНОГО БЕЛКА В ПАТОГЕНЕЗЕ СОСУДИСТЫХ ЗАБОЛЕВАНИЙ ОРГАНА ЗРЕНИЯ У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 114-121.

Pogosov S. et al. Psychogenetic properties of drug patients as risk factors for the formation of addiction //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 186-191.

Sedenkova M. et al. The possibility of predicting the time of formation and development of alcohol dependence: the role of genetic risk, family weight and its level //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 173-178.

Shamilov V. et al. Disorders of decision-making in the case of depression: clinical evaluation and correlation with eeg indicators //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 198-204.

Uskov A. et al. Modern methods of therapeutic fasting as a way to overcome the pharmacoresistance of mental pathology //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 179-185.

Prostyakova N. et al. Strategy for early diagnosis with cardiovascular diseaseisomatized mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 166-172.

Tahirova, J., Roziklov, N., Mamatkulova, F., & Shernazarov, F. (2022). Insomnia problem causes of sleep disorder, help measures at home. Science and innovation, 1(D8), 521-525.

Qizi T. J. I., Farrukh S. Treatment of myocardial infarction and first aid //Science and innovation. – 2022. – Т. 1. – №. D3. – С. 317-320.

Rotanov A. et al. Elderly epilepsy: neurophysiological aspects of non-psychotic mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 192-197.

Abdurakhmanov I., Shernazarov F. SPECIFIC ASPECTS OF TREATMENT OF CHRONIC RHINOSINUSITIS IN CHILDREN //Science and innovation. – 2023. – Т. 2. – №. D10. – С. 164-168.

Tahirova J. et al. Neurose causes and mechanisms of development, symptoms, treatment, prevention //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 515-520.

Tahirova J., Shernazarov F. Symptoms of hymoritis, treatment, methods of folk medicine, prevention //Science and innovation. – 2022. – Т. 1. – №. D8. – С. 983-990.

Shodiyeva D., Shernazarov F. Analysis of the compounds providing antihelmitic effects of chichorium intybus through fractionation. Science and innovation, 2 (D2), 64-70. – 2023.

Jalalova D., Normatova N., Shernazarov F. Genetic markers for the development of diabetic retinopathy //Science and Innovation. – 2022. – Т. 1. – №. 8. – С. 919-923.

Abdukodirova S., Shernazarov F. SPECIFIC CHARACTERISTICS AND TREATMENT OF ACUTE OBSTRUCTIVE BRONCHITIS IN CHILDREN OF EARLY AGE //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 5-8.